110
Participants
Start Date
June 1, 2017
Primary Completion Date
March 13, 2019
Study Completion Date
November 15, 2022
Mifépristone versus Misoprostol
The women will be randomized into two groups: Mifépristone group and Misoprostol group. The main endpoint will be the per-operating pain. The other endpoints are the pre and post-operative pain, the complications (cervical tearing, uterine perforation, hemorrhage requiring the use of blood products or an hemostatic intervention), the surgical time necessary to terminate the pregnancy, the side-effects of the drugs. The amount of per-operating bleeding and the duration of the intervention . The investigators assume that the use of Mifepristone in the cervical preparation of the surgical abortion under LA would reduce the per-operating pain. The number of patients required is 55 in each arm.
Hôpital de la conception Assistance Publique Hôpitaux de Marseille, Marseille
Assistance Publique Hopitaux De Marseille
OTHER